Genomics, Proteomics, & Metabolomics
|4 min read
New CRISPR Toolkit to Allow Remote-Controlled Genome Editing
USC Viterbi biomedical engineers harness focused ultrasound to revolutionize CRISPR’s capabilities to treat countless diseasesUpdated |3 min read
Barcelona Launches World’s First Evolutionary Medical Genomics Program
CRG, UPF, and IBE researchers are teaming up to explore the evolutionary underpinnings of disease at the molecular level|2 min read
AMP Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories
The review is authored by a multidisciplinary team of experts from AMP and APHL, including the SARS-CoV-2 Whole Genome Sequencing Working Group|2 min read
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
The test enables precise detection of a range of complex genomic alterations that are features of many rare diseases and undetectable by traditional approaches|1 min read
Optimizing Oncology Workflows in the NGS Era
A guide to effective utilization of NGS for liquid and tissue biopsiesSponsored by
|2 min read
'The Age of Artificial Intelligence'
The Today's Clinical Lab 2024 Genetics & Genomics print issue features insights on how to harness the power of genetics and genomics data analytics|2 min read
Emerging Technologies Guide: November 2024
Recent new and emerging technologies in the field of laboratory medicine from the 2024 November Genetics & Genomics issue of Today's Clinical Lab|2 min read
Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis
The genes, involved in both diseases, could serve as targets for diagnosis and treatment|2 min read
High Levels of Omega-3, Omega-6 May Protect Against Cancer
Fish oil supplements could help guard against overall risk of developing cancer|4 min read
One in a Million: A Nationwide Diagnostics Strategy for Ultrarare Diseases
Leveraging integrated healthcare frameworks can significantly reduce diagnostic delays|1 min read
Targeted Treatment Breakthrough for Aggressive Childhood Brain Cancer
New research identifies a critical genetic variation in Group 3 medulloblastomas, paving the way for improved diagnostic and treatment strategies for this challenging form of pediatric brain cancer|2 min read















